Tech Company Inital Public Offerings
Five Prime Therapeutics IPO
On 9/18/2013, Five Prime Therapeutics completed its IPO
Transaction Overview
Company Name
Announced On
9/18/2013
Transaction Type
IPO
Amount
$62,400,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
111 Oyster Point Blvd.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Ringo
Chief Financial Officer
David Smith
Chief Medical Officer
Helen Collins
VP - Bus. Development
Francis Sarena
VP - Operations
Nallakkan Arvindan
Browse more venture capital transactions:
Prev: 9/18/2013: Simplilearn venture capital transaction
Next: 9/18/2013: Remind venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs